
A recent study reveals significant progress in biomarker testing for lung cancer in community settings, highlighting the need for improved access to targeted therapies.

Your AI-Trained Oncology Knowledge Connection!

Kenneth Kehl, MD, MPH, is a medical oncologist at Dana-Farber Cancer Institute.